Nicholas L Angeloni
Overview
Explore the profile of Nicholas L Angeloni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
440
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Plebanek M, Angeloni N, Vinokour E, Li J, Henkin A, Martinez-Marin D, et al.
Nat Commun
. 2017 Nov;
8(1):1319.
PMID: 29105655
Metastatic cancers produce exosomes that condition pre-metastatic niches in remote microenvironments to favor metastasis. In contrast, here we show that exosomes from poorly metastatic melanoma cells can potently inhibit metastasis...
2.
McMahon K, Scielzo C, Angeloni N, Deiss-Yehiely E, Scarfo L, Ranghetti P, et al.
Oncotarget
. 2017 Jan;
8(7):11219-11227.
PMID: 28061439
Chronic lymphocytic leukemia (CLL) remains incurable despite the introduction of new drugs. Therapies targeting receptors and pathways active specifically in malignant B cells might provide better treatment options. For instance,...
3.
Angeloni N, McMahon K, Swaminathan S, Plebanek M, Osman I, Volpert O, et al.
Sci Rep
. 2016 Mar;
6:22915.
PMID: 26964503
Exosomes are produced by cells to mediate intercellular communication, and have been shown to perpetuate diseases, including cancer. New tools are needed to understand exosome biology, detect exosomes from specific...
4.
McMahon K, Foit L, Angeloni N, Giles F, Gordon L, Thaxton C
Cancer Treat Res
. 2015 Apr;
166:129-50.
PMID: 25895867
High-density lipoproteins (HDL) are diverse natural nanoparticles that carry cholesterol and are best known for the role that they play in cardiovascular disease. However, due to their unique targeting capabilities,...
5.
Halo T, McMahon K, Angeloni N, Xu Y, Wang W, Chinen A, et al.
Proc Natl Acad Sci U S A
. 2014 Nov;
111(48):17104-9.
PMID: 25404304
Metastasis portends a poor prognosis for cancer patients. Primary tumor cells disseminate through the bloodstream before the appearance of detectable metastatic lesions. The analysis of cancer cells in blood—so-called circulating...
6.
Angeloni N, Bond C, McVary K, Podlasek C
PLoS One
. 2013 Aug;
8(8):e70985.
PMID: 23967143
Erectile dysfunction (ED) is a debilitating medical condition and current treatments are ineffective in patients with cavernous nerve (CN) injury, due to penile remodeling and apoptosis. A critical regulator of...
7.
Angeloni N, Bond C, Tang Y, Harrington D, Zhang S, Stupp S, et al.
Biomaterials
. 2010 Oct;
32(4):1091-101.
PMID: 20971506
SHH plays a significant role in peripheral nerve regeneration and has clinical potential to be used as a regenerative therapy for the CN in prostatectomy patients and in other patients...
8.
Bond C, Angeloni N, Harrington D, Stupp S, McKenna K, Podlasek C
J Sex Med
. 2010 Sep;
8(1):78-89.
PMID: 20807324
Introduction: Erectile dysfunction (ED) is a serious medical condition that affects 16-82% of prostate cancer patients treated by radical prostatectomy and current treatments are ineffective in 50-60% of prostatectomy patients....
9.
Bond C, Angeloni N, Podlasek C
J Sex Med
. 2009 Nov;
7(3):1116-25.
PMID: 19929920
Introduction: Smooth muscle apoptosis is a major contributing factor to erectile dysfunction (ED) development in prostatectomy and diabetic patients and animal models. A critical regulator of penile smooth muscle and...
10.
Angeloni N, Bond C, Monsivais D, Tang Y, Podlasek C
J Sex Med
. 2009 Jun;
6(9):2480-93.
PMID: 19515211
Introduction: Sonic hedgehog (SHH) is an essential regulator of smooth muscle apoptosis in the penis that has significant clinical potential as a therapy to suppress post-prostatectomy apoptosis, an underlying cause...